Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
Identifieur interne : 000977 ( Main/Corpus ); précédent : 000976; suivant : 000978Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
Auteurs : Piero Ruscitti ; Federico Bruno ; Onorina Berardicurti ; Chiara Acanfora ; Viktoriya Pavlych ; Pierpaolo Palumbo ; Alessandro Conforti ; Francesco Carubbi ; Ilenia Di Cola ; Paola Di Benedetto ; Paola Cipriani ; Davide Grassi ; Carlo Masciocchi ; Annamaria Iagnocco ; Antonio Barile ; Roberto GiacomelliSource :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.
English descriptors
- KwdEn :
- Aged (MeSH), Artificial Intelligence (MeSH), Betacoronavirus (MeSH), Coronavirus Infections (diagnostic imaging), Coronavirus Infections (pathology), Coronavirus Infections (virology), Cross-Sectional Studies (MeSH), Female (MeSH), Humans (MeSH), Lung (diagnostic imaging), Lung (pathology), Lung (virology), Macrophage Activation Syndrome (diagnostic imaging), Macrophage Activation Syndrome (pathology), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (diagnostic imaging), Pneumonia, Viral (pathology), Pneumonia, Viral (virology), Retrospective Studies (MeSH), Tomography, X-Ray Computed (methods).
- MESH :
- diagnostic imaging : Coronavirus Infections, Lung, Macrophage Activation Syndrome, Pneumonia, Viral.
- methods : Tomography, X-Ray Computed.
- pathology : Coronavirus Infections, Lung, Macrophage Activation Syndrome, Pneumonia, Viral.
- virology : Coronavirus Infections, Lung, Pneumonia, Viral.
- Aged, Artificial Intelligence, Betacoronavirus, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pandemics, Retrospective Studies.
Abstract
OBJECTIVES
To evaluate the clinical pictures, laboratory tests and imaging of patients with lung involvement, either from severe COVID-19 or macrophage activation syndrome (MAS), in order to assess how similar these two diseases are.
METHODS
The present work has been designed as a cross-sectional single-centre study to compare characteristics of patients with lung involvement either from MAS or severe COVID-19. Chest CT scans were assessed by using an artificial intelligence (AI)-based software.
RESULTS
Ten patients with MAS and 47 patients with severe COVID-19 with lung involvement were assessed. Although all patients showed fever and dyspnoea, patients with MAS were characterised by thrombocytopaenia, whereas patients with severe COVID-19 were characterised by lymphopaenia and neutrophilia. Higher values of H-score characterised patients with MAS when compared with severe COVID-19. AI-reconstructed images of chest CT scan showed that apical, basal, peripheral and bilateral distributions of ground-glass opacities (GGOs), as well as apical consolidations, were more represented in severe COVID-19 than in MAS. C reactive protein directly correlated with GGOs extension in both diseases. Furthermore, lymphopaenia inversely correlated with GGOs extension in severe COVID-19.
CONCLUSIONS
Our data could suggest laboratory and radiological differences between MAS and severe COVID-19, paving the way for further hypotheses to be investigated in future confirmatory studies.
DOI: 10.1136/annrheumdis-2020-218048
PubMed: 32719039
PubMed Central: PMC7456556
Links to Exploration step
pubmed:32719039Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.</title>
<author><name sortKey="Ruscitti, Piero" sort="Ruscitti, Piero" uniqKey="Ruscitti P" first="Piero" last="Ruscitti">Piero Ruscitti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bruno, Federico" sort="Bruno, Federico" uniqKey="Bruno F" first="Federico" last="Bruno">Federico Bruno</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berardicurti, Onorina" sort="Berardicurti, Onorina" uniqKey="Berardicurti O" first="Onorina" last="Berardicurti">Onorina Berardicurti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Acanfora, Chiara" sort="Acanfora, Chiara" uniqKey="Acanfora C" first="Chiara" last="Acanfora">Chiara Acanfora</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pavlych, Viktoriya" sort="Pavlych, Viktoriya" uniqKey="Pavlych V" first="Viktoriya" last="Pavlych">Viktoriya Pavlych</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Palumbo, Pierpaolo" sort="Palumbo, Pierpaolo" uniqKey="Palumbo P" first="Pierpaolo" last="Palumbo">Pierpaolo Palumbo</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Conforti, Alessandro" sort="Conforti, Alessandro" uniqKey="Conforti A" first="Alessandro" last="Conforti">Alessandro Conforti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carubbi, Francesco" sort="Carubbi, Francesco" uniqKey="Carubbi F" first="Francesco" last="Carubbi">Francesco Carubbi</name>
<affiliation><nlm:affiliation>Department of Medicine, ASL 1 Avezzano Sulmona L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Cola, Ilenia" sort="Di Cola, Ilenia" uniqKey="Di Cola I" first="Ilenia" last="Di Cola">Ilenia Di Cola</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Benedetto, Paola" sort="Di Benedetto, Paola" uniqKey="Di Benedetto P" first="Paola" last="Di Benedetto">Paola Di Benedetto</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cipriani, Paola" sort="Cipriani, Paola" uniqKey="Cipriani P" first="Paola" last="Cipriani">Paola Cipriani</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grassi, Davide" sort="Grassi, Davide" uniqKey="Grassi D" first="Davide" last="Grassi">Davide Grassi</name>
<affiliation><nlm:affiliation>Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Masciocchi, Carlo" sort="Masciocchi, Carlo" uniqKey="Masciocchi C" first="Carlo" last="Masciocchi">Carlo Masciocchi</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Iagnocco, Annamaria" sort="Iagnocco, Annamaria" uniqKey="Iagnocco A" first="Annamaria" last="Iagnocco">Annamaria Iagnocco</name>
<affiliation><nlm:affiliation>Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Torino, Piemonte, Italy annamaria.iagnocco1@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Barile, Antonio" sort="Barile, Antonio" uniqKey="Barile A" first="Antonio" last="Barile">Antonio Barile</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giacomelli, Roberto" sort="Giacomelli, Roberto" uniqKey="Giacomelli R" first="Roberto" last="Giacomelli">Roberto Giacomelli</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32719039</idno>
<idno type="pmid">32719039</idno>
<idno type="doi">10.1136/annrheumdis-2020-218048</idno>
<idno type="pmc">PMC7456556</idno>
<idno type="wicri:Area/Main/Corpus">000977</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000977</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.</title>
<author><name sortKey="Ruscitti, Piero" sort="Ruscitti, Piero" uniqKey="Ruscitti P" first="Piero" last="Ruscitti">Piero Ruscitti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bruno, Federico" sort="Bruno, Federico" uniqKey="Bruno F" first="Federico" last="Bruno">Federico Bruno</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berardicurti, Onorina" sort="Berardicurti, Onorina" uniqKey="Berardicurti O" first="Onorina" last="Berardicurti">Onorina Berardicurti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Acanfora, Chiara" sort="Acanfora, Chiara" uniqKey="Acanfora C" first="Chiara" last="Acanfora">Chiara Acanfora</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pavlych, Viktoriya" sort="Pavlych, Viktoriya" uniqKey="Pavlych V" first="Viktoriya" last="Pavlych">Viktoriya Pavlych</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Palumbo, Pierpaolo" sort="Palumbo, Pierpaolo" uniqKey="Palumbo P" first="Pierpaolo" last="Palumbo">Pierpaolo Palumbo</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Conforti, Alessandro" sort="Conforti, Alessandro" uniqKey="Conforti A" first="Alessandro" last="Conforti">Alessandro Conforti</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carubbi, Francesco" sort="Carubbi, Francesco" uniqKey="Carubbi F" first="Francesco" last="Carubbi">Francesco Carubbi</name>
<affiliation><nlm:affiliation>Department of Medicine, ASL 1 Avezzano Sulmona L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Cola, Ilenia" sort="Di Cola, Ilenia" uniqKey="Di Cola I" first="Ilenia" last="Di Cola">Ilenia Di Cola</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Benedetto, Paola" sort="Di Benedetto, Paola" uniqKey="Di Benedetto P" first="Paola" last="Di Benedetto">Paola Di Benedetto</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cipriani, Paola" sort="Cipriani, Paola" uniqKey="Cipriani P" first="Paola" last="Cipriani">Paola Cipriani</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grassi, Davide" sort="Grassi, Davide" uniqKey="Grassi D" first="Davide" last="Grassi">Davide Grassi</name>
<affiliation><nlm:affiliation>Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Masciocchi, Carlo" sort="Masciocchi, Carlo" uniqKey="Masciocchi C" first="Carlo" last="Masciocchi">Carlo Masciocchi</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Iagnocco, Annamaria" sort="Iagnocco, Annamaria" uniqKey="Iagnocco A" first="Annamaria" last="Iagnocco">Annamaria Iagnocco</name>
<affiliation><nlm:affiliation>Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Torino, Piemonte, Italy annamaria.iagnocco1@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Barile, Antonio" sort="Barile, Antonio" uniqKey="Barile A" first="Antonio" last="Barile">Antonio Barile</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giacomelli, Roberto" sort="Giacomelli, Roberto" uniqKey="Giacomelli R" first="Roberto" last="Giacomelli">Roberto Giacomelli</name>
<affiliation><nlm:affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Artificial Intelligence (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (diagnostic imaging)</term>
<term>Coronavirus Infections (pathology)</term>
<term>Coronavirus Infections (virology)</term>
<term>Cross-Sectional Studies (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Lung (diagnostic imaging)</term>
<term>Lung (pathology)</term>
<term>Lung (virology)</term>
<term>Macrophage Activation Syndrome (diagnostic imaging)</term>
<term>Macrophage Activation Syndrome (pathology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnostic imaging)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Tomography, X-Ray Computed (methods)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Macrophage Activation Syndrome</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Macrophage Activation Syndrome</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Artificial Intelligence</term>
<term>Betacoronavirus</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Retrospective Studies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>To evaluate the clinical pictures, laboratory tests and imaging of patients with lung involvement, either from severe COVID-19 or macrophage activation syndrome (MAS), in order to assess how similar these two diseases are.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>The present work has been designed as a cross-sectional single-centre study to compare characteristics of patients with lung involvement either from MAS or severe COVID-19. Chest CT scans were assessed by using an artificial intelligence (AI)-based software.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Ten patients with MAS and 47 patients with severe COVID-19 with lung involvement were assessed. Although all patients showed fever and dyspnoea, patients with MAS were characterised by thrombocytopaenia, whereas patients with severe COVID-19 were characterised by lymphopaenia and neutrophilia. Higher values of H-score characterised patients with MAS when compared with severe COVID-19. AI-reconstructed images of chest CT scan showed that apical, basal, peripheral and bilateral distributions of ground-glass opacities (GGOs), as well as apical consolidations, were more represented in severe COVID-19 than in MAS. C reactive protein directly correlated with GGOs extension in both diseases. Furthermore, lymphopaenia inversely correlated with GGOs extension in severe COVID-19.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Our data could suggest laboratory and radiological differences between MAS and severe COVID-19, paving the way for further hypotheses to be investigated in future confirmatory studies.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32719039</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>79</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.</ArticleTitle>
<Pagination><MedlinePgn>1152-1155</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-218048</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES">To evaluate the clinical pictures, laboratory tests and imaging of patients with lung involvement, either from severe COVID-19 or macrophage activation syndrome (MAS), in order to assess how similar these two diseases are.</AbstractText>
<AbstractText Label="METHODS">The present work has been designed as a cross-sectional single-centre study to compare characteristics of patients with lung involvement either from MAS or severe COVID-19. Chest CT scans were assessed by using an artificial intelligence (AI)-based software.</AbstractText>
<AbstractText Label="RESULTS">Ten patients with MAS and 47 patients with severe COVID-19 with lung involvement were assessed. Although all patients showed fever and dyspnoea, patients with MAS were characterised by thrombocytopaenia, whereas patients with severe COVID-19 were characterised by lymphopaenia and neutrophilia. Higher values of H-score characterised patients with MAS when compared with severe COVID-19. AI-reconstructed images of chest CT scan showed that apical, basal, peripheral and bilateral distributions of ground-glass opacities (GGOs), as well as apical consolidations, were more represented in severe COVID-19 than in MAS. C reactive protein directly correlated with GGOs extension in both diseases. Furthermore, lymphopaenia inversely correlated with GGOs extension in severe COVID-19.</AbstractText>
<AbstractText Label="CONCLUSIONS">Our data could suggest laboratory and radiological differences between MAS and severe COVID-19, paving the way for further hypotheses to be investigated in future confirmatory studies.</AbstractText>
<CopyrightInformation>© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ruscitti</LastName>
<ForeName>Piero</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Bruno</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berardicurti</LastName>
<ForeName>Onorina</ForeName>
<Initials>O</Initials>
<Identifier Source="ORCID">0000-0002-2808-1581</Identifier>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Acanfora</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pavlych</LastName>
<ForeName>Viktoriya</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Palumbo</LastName>
<ForeName>Pierpaolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Conforti</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carubbi</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0003-1958-5136</Identifier>
<AffiliationInfo><Affiliation>Department of Medicine, ASL 1 Avezzano Sulmona L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Di Cola</LastName>
<ForeName>Ilenia</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Di Benedetto</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">0000-0003-2927-8703</Identifier>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cipriani</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grassi</LastName>
<ForeName>Davide</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Masciocchi</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Iagnocco</LastName>
<ForeName>Annamaria</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Torino, Piemonte, Italy annamaria.iagnocco1@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Barile</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Giacomelli</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0003-0670-9638</Identifier>
<AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055501" MajorTopicYN="N">Macrophage Activation Syndrome</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">arthritis, juvenile</Keyword>
<Keyword MajorTopicYN="Y">inflammation</Keyword>
<Keyword MajorTopicYN="Y">still's disease, adult-onset</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>07</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32719039</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-218048</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-218048</ArticleId>
<ArticleId IdType="pmc">PMC7456556</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Arthritis Res Ther. 2020 Jun 22;22(1):151</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32571407</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2020 May 28;11:1130</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32574264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Autoimmun Rev. 2020 Jul;19(7):102562</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32376400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2005 Apr 16-22;365(9468):1429-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15836892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Cancer. 2018 Aug;18(8):500-510</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29777175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiol Med. 2020 May;125(5):505-508</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32350794</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Jul;2(7):e437-e445</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32835247</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2014 Apr 26;383(9927):1503-1516</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24290661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Signal Transduct Target Ther. 2020 Mar 27;5(1):33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32296069</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheumatol. 2014 Sep;66(9):2613-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24782338</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheumatol. 2019 Nov;71(11):1943-1954</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31379071</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2016 May;149(5):1294-301</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26836913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 2018 Jun;45(6):864-872</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29657144</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 1987 Feb;30(2):186-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3827959</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Jul;8(7):681-686</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32473124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 2020 May 1;47(5):639-642</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32209661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Autoimmun Rev. 2020 Jun;19(6):102537</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32251717</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2008 Mar;246(3):697-722</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18195376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 1992 Mar;19(3):424-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1578458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2019 Dec;78(12):1722-1731</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31562126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000977 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000977 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidSeniorV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32719039 |texte= Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32719039" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidSeniorV1
This area was generated with Dilib version V0.6.37. |